Medidata Solutions Inc. (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company's plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments. Study Design Optimization enables customers to gain visibility into the impact of protocol elements on resource and trial endpoints. Grants Manager compares specific industry benchmarks and analytics, using industry's database of negotiated procedure costs, to support appropriate grants to investigator sites and automated negotiations with multiple investigator sites. Payments enables customers to establish a global investigator payment strategy and process to automate payment calculation, distribution and reporting, including tax and currency exchange calculations.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: IT Services & Consulting - NEC
- Sub-Industry: Health Care Technology
- Symbol: NASDAQ:MDSO
- CUSIP: 58471A10
- Web: www.mdsol.com
Capitalization:- Market Cap: $4.2322 billion
- Outstanding Shares: 58,504,000
Average Prices:- 50 Day Moving Avg: $77.26
- 200 Day Moving Avg: $67.12
- 52 Week Range: $46.10 - $85.92
P/E:- Trailing P/E Ratio: 116.87
- Foreward P/E Ratio: 73.07
- P/E Growth: 2.88
Sales & Book Value:- Annual Revenue: $508.77 million
- Price / Sales: 8.32
- Book Value: $7.82 per share
- Price / Book: 9.25
Profitability:- EBIDTA: $76.83 million
- Net Margins: 7.07%
- Return on Equity: 11.14%
- Return on Assets: 5.49%
Debt:- Debt-to-Equity Ratio: 0.61%
- Current Ratio: 3.37%
- Quick Ratio: 3.37%
Misc:- Average Volume: 681,398 shs.
- Beta: 1.79
- Short Ratio: 5.56
Frequently Asked Questions for Medidata Solutions (NASDAQ:MDSO)
What is Medidata Solutions' stock symbol?
Medidata Solutions trades on the NASDAQ under the ticker symbol "MDSO."
How were Medidata Solutions' earnings last quarter?
Medidata Solutions, Inc. (NASDAQ:MDSO) issued its earnings results on Tuesday, July, 18th. The company reported $0.31 EPS for the quarter, beating analysts' consensus estimates of $0.28 by $0.03. The firm had revenue of $137.41 million for the quarter, compared to the consensus estimate of $134.28 million. Medidata Solutions had a return on equity of 11.14% and a net margin of 7.07%. The business's quarterly revenue was up 19.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.24 earnings per share. View Medidata Solutions' Earnings History.
When will Medidata Solutions make its next earnings announcement?
Where is Medidata Solutions' stock going? Where will Medidata Solutions' stock price be in 2017?
11 equities research analysts have issued twelve-month target prices for Medidata Solutions' stock. Their predictions range from $46.00 to $95.00. On average, they anticipate Medidata Solutions' stock price to reach $78.45 in the next twelve months. View Analyst Ratings for Medidata Solutions.
What are analysts saying about Medidata Solutions stock?
Here are some recent quotes from research analysts about Medidata Solutions stock:
- 1. According to Zacks Investment Research, "Medidata Solutions is a leading global provider of hosted clinical development solutions that enhance the efficiency of customers' clinical development processes and optimize their research and development investments. Medidata products and services allow customers to achieve clinical results more efficiently and effectively by streamlining the design, planning and management of key aspects of the clinical development process, including protocol development (Medidata Designer), investigator benchmarking and budgeting (Medidata Grants Manager), contract research organization (CRO) benchmarking and budgeting (Medidata CRO Contractor), and the capture, management, analysis and reporting of clinical trial data (Medidata Rave). Medidata's diverse customer base spans pharmaceutical, biotechnology and medical device companies, academic institutions, CROs and other research organizations, and includes some top global pharmaceutical companies. " (7/21/2017)
- 2. Jefferies Group LLC analysts commented, "Based on several triangulations, FY17 revenue guidance appears to mark a very accurate target at the midpoint (not too high or low). The 18.7% midpoint growth would need to further accelerate to 22% in '18-'20 to achieve management's $1B goal by '20. Beating the '16 sales performance seems like a tall order. MDSO now trades at 5.6x '17 revenue compared to 4.4x for SaaS peers with similar growth." (2/10/2017)
Who are some of Medidata Solutions' key competitors?
Some companies that are related to Medidata Solutions include Akamai Technologies (AKAM), Jack Henry & Associates (JKHY), F5 Networks (FFIV), Fortinet (FTNT), LogMein (LOGM), CSRA (CSRA), Booz Allen Hamilton Holding Corporation (BAH), GoDaddy (GDDY), Aspen Technology (AZPN), NCR Corporation (NCR), EPAM Systems (EPAM), Teradata Corporation (TDC), Proofpoint (PFPT), InterXion Holding N.V. (INXN), DST Systems (DST), SCIENCE APPLICATIONS INTERNATIONAL CORPORATION (SAIC), CACI International (CACI) and NetScout Systems (NTCT).
Who are Medidata Solutions' key executives?
Medidata Solutions' management team includes the folowing people:
- Tarek A. Sherif, Chairman of the Board, Chief Executive Officer
- Glen M. de Vries, President, Director
- Rouven Bergmann, Chief Financial Officer
- Michael L. Capone, Chief Operating Officer
- Michael I. Otner, Executive Vice President, General Counsel, Corporate Secretary
- Michael Christopher Pray, Executive Vice President, General Manager - Global Sales
- Mary Weger, Executive Vice President—Human Resources
- Carlos Dominguez, Independent Director
- Neil M. Kurtz M.D., Independent Director
- George W. McCulloch, Independent Director
Who owns Medidata Solutions stock?
Medidata Solutions' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (8.06%), FMR LLC (6.62%), State Street Corp (3.13%), New York State Common Retirement Fund (1.79%), Northern Trust Corp (1.65%) and Janus Henderson Group PLC (1.51%). Company insiders that own Medidata Solutions stock include Eileen Schloss, Lee Shapiro, Michael I Otner, Michael L Capone, Neil M Kurtz, Robert Taylor, Steven Isaac Hirschfeld, Tarek Sherif and Vries Glen Michael De. View Institutional Ownership Trends for Medidata Solutions.
Who sold Medidata Solutions stock? Who is selling Medidata Solutions stock?
Medidata Solutions' stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Global Thematic Partners LLC, Vanguard Group Inc., Renaissance Technologies LLC, Principal Financial Group Inc., Fred Alger Management Inc., Fiera Capital Corp and Frontier Capital Management Co. LLC. Company insiders that have sold Medidata Solutions stock in the last year include Eileen Schloss, Michael I Otner, Michael L Capone, Robert Taylor, Steven Isaac Hirschfeld, Tarek Sherif and Vries Glen Michael De. View Insider Buying and Selling for Medidata Solutions.
Who bought Medidata Solutions stock? Who is buying Medidata Solutions stock?
Medidata Solutions' stock was acquired by a variety of institutional investors in the last quarter, including State Street Corp, Voya Investment Management LLC, Northern Trust Corp, Stifel Financial Corp, Columbus Circle Investors, Retirement Systems of Alabama, Nationwide Fund Advisors and State of Wisconsin Investment Board. View Insider Buying and Selling for Medidata Solutions.
How do I buy Medidata Solutions stock?
Shares of Medidata Solutions can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Medidata Solutions' stock price today?
One share of Medidata Solutions stock can currently be purchased for approximately $72.34.
MarketBeat Community Rating for Medidata Solutions (NASDAQ MDSO)MarketBeat's community ratings are surveys of what our community members think about Medidata Solutions and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Medidata Solutions (NASDAQ:MDSO) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 1 Hold Rating, 10 Buy Ratings |
| Consensus Rating: | Buy (Score: 2.91) |
| Consensus Price Target: | $78.45 (8.45% upside) |
Analysts' Ratings History for Medidata Solutions (NASDAQ:MDSO)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 7/24/2017 | Citigroup Inc. | Reiterated Rating | Buy | $94.00 -> $95.00 | Low |  |
| 7/21/2017 | Needham & Company LLC | Reiterated Rating | Buy | $75.00 -> $90.00 | Low | |
| 7/20/2017 | Morgan Stanley | Boost Price Target | Overweight | $74.00 -> $86.00 | Low | |
| 7/18/2017 | J P Morgan Chase & Co | Boost Price Target | Overweight | $87.00 | High | |
| 7/7/2017 | Piper Jaffray Companies | Boost Price Target | Overweight | $87.00 | High | |
| 6/27/2017 | SunTrust Banks, Inc. | Boost Price Target | Buy | $80.00 -> $90.00 | Low | |
| 6/6/2017 | Bank of America Corporation | Initiated Coverage | Buy -> Buy | $85.00 | High | |
| 5/11/2017 | KeyCorp | Boost Price Target | Overweight | $71.00 -> $74.00 | Low | |
| 5/1/2017 | Jefferies Group LLC | Upgrade | Underperform -> Hold | $47.00 -> $46.00 | Medium | |
| 12/4/2016 | Pacific Crest | Set Price Target | Buy | $65.00 | N/A | |
| 9/13/2016 | Deutsche Bank AG | Boost Price Target | Buy | $56.00 -> $58.00 | N/A | |
| 7/21/2016 | Wells Fargo & Company | Downgrade | Outperform -> Market Perform | | N/A | |
| 4/25/2016 | Leerink Swann | Reiterated Rating | Market Perform | | N/A | |
| 4/22/2016 | Topeka Capital Markets | Reiterated Rating | Buy | $44.00 -> $51.00 | N/A | |
| 10/28/2015 | Stifel Nicolaus | Lower Price Target | Buy | $65.00 -> $60.00 | N/A | |
(Data available from 8/21/2015 forward)
Earnings History for Medidata Solutions (NASDAQ:MDSO)Earnings History by Quarter for Medidata Solutions (NASDAQ MDSO)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/23/2017 | | $0.31 | | | | | N/A | |
| 7/18/2017 | Q2 2017 | $0.28 | $0.31 | $134.28 million | $137.41 million | View | N/A | |
| 4/26/2017 | Q1 2017 | $0.11 | $0.31 | $125.90 million | $126.80 million | View | N/A | |
| 2/9/2017 | Q416 | $0.26 | $0.33 | $124.15 million | $124.50 million | View | Listen | |
| 10/25/2016 | Q316 | $0.26 | $0.28 | $118.96 million | $120.10 million | View | Listen | |
| 7/20/2016 | Q216 | $0.23 | $0.24 | $112.39 million | $114.60 million | View | Listen | |
| 4/21/2016 | Q116 | $0.18 | $0.25 | $103.22 million | $104.20 million | View | Listen | |
| 2/10/2016 | Q415 | $0.24 | $0.27 | $105.09 million | $98.90 million | View | Listen | |
| 10/27/2015 | Q315 | $0.24 | $0.12 | $103.49 million | $103.10 million | View | Listen | |
| 7/21/2015 | Q215 | $0.20 | $0.22 | $97.27 million | $98.10 million | View | Listen | |
| 4/23/2015 | Q115 | $0.02 | $0.17 | $91.05 million | $92.40 million | View | Listen | |
| 2/5/2015 | Q414 | $0.10 | $0.15 | $91.12 million | $89.20 million | View | Listen | |
| 10/28/2014 | Q314 | $0.22 | $0.20 | $87.72 million | $86.00 million | View | N/A | |
| 7/29/2014 | Q214 | $0.07 | $0.04 | $81.90 million | $83.20 million | View | Listen | |
| 4/22/2014 | Q114 | $0.16 | $0.11 | $79.50 million | $76.60 million | View | Listen | |
| 2/6/2014 | Q413 | $0.17 | $0.23 | $73.97 million | $74.60 million | View | Listen | |
| 10/24/2013 | Q313 | $0.33 | $0.40 | $70.74 million | $70.90 million | View | N/A | |
| 7/25/2013 | Q2 2013 | $0.12 | $0.20 | $66.71 million | $68.07 million | View | N/A | |
| 4/29/2013 | Q1 2013 | $0.23 | $0.35 | $61.32 million | $63.30 million | View | N/A | |
| 2/21/2013 | Q4 2012 | $0.28 | $0.35 | $59.12 million | $58.60 million | View | N/A | |
| 10/31/2012 | | $0.31 | $0.29 | | | View | N/A | |
| 7/31/2012 | | $0.23 | $0.23 | | | View | N/A | |
| 5/1/2012 | | $0.22 | $0.26 | | | View | N/A | |
| 3/6/2012 | | $0.37 | $0.37 | | | View | N/A | |
| 11/8/2011 | | $0.34 | $0.42 | | | View | N/A | |
| 8/9/2011 | | $0.33 | $0.40 | | | View | N/A | |
| 5/10/2011 | | $0.23 | $0.21 | | | View | N/A | |
| 3/15/2011 | | $0.26 | $0.29 | | | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for Medidata Solutions (NASDAQ:MDSO)2017 EPS Consensus Estimate: $0.69
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 1 | $0.11 | $0.11 | $0.11 |
| Q2 2017 | 1 | $0.16 | $0.16 | $0.16 |
| Q3 2017 | 2 | $0.19 | $0.20 | $0.20 |
| Q4 2017 | 2 | $0.22 | $0.23 | $0.23 |
(Data provided by Zacks Investment Research)
Dividend History for Medidata Solutions (NASDAQ:MDSO)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Medidata Solutions (NASDAQ:MDSO)Insider Ownership Percentage: 5.80%
Insider Trades by Quarter for Medidata Solutions (NASDAQ:MDSO)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 8/15/2017 | Michael L. Capone | COO | Sell | 5,000 | $74.53 | $372,650.00 | |
| 6/5/2017 | Robert Taylor | Director | Sell | 5,639 | $73.46 | $414,240.94 | |
| 5/15/2017 | Michael L Capone | COO | Sell | 5,000 | $69.46 | $347,300.00 | |
| 5/1/2017 | Michael I Otner | EVP | Sell | 7,500 | $66.39 | $497,925.00 | |
| 4/4/2017 | Tarek Sherif | CEO | Sell | 2,964 | $57.08 | $169,185.12 | |
| 3/9/2017 | Vries Glen Michael De | President | Sell | 7,500 | $56.05 | $420,375.00 | |
| 3/2/2017 | Tarek Sherif | CEO | Sell | 7,500 | $57.06 | $427,950.00 | |
| 2/14/2017 | Michael L. Capone | COO | Sell | 5,000 | $56.14 | $280,700.00 | |
| 1/25/2017 | Steven Isaac Hirschfeld | Vice Chairman | Sell | 10,000 | $50.83 | $508,300.00 | |
| 1/11/2017 | Vries Glen Michael De | President | Sell | 7,500 | $52.44 | $393,300.00 | |
| 1/4/2017 | Tarek Sherif | CEO | Sell | 7,500 | $51.56 | $386,700.00 | |
| 12/21/2016 | Steven Isaac Hirschfeld | Vice Chairman | Sell | 10,000 | $51.02 | $510,200.00 | |
| 12/2/2016 | Tarek Sherif | CEO | Sell | 7,500 | $52.68 | $395,100.00 | |
| 11/30/2016 | Steven Isaac Hirschfeld | Vice Chairman | Sell | 10,000 | $54.87 | $548,700.00 | |
| 11/16/2016 | Eileen Schloss | EVP | Sell | 3,831 | $56.60 | $216,834.60 | |
| 11/16/2016 | Steven Isaac Hirschfeld | Vice Chairman | Sell | 156 | $57.85 | $9,024.60 | |
| 11/9/2016 | Vries Glen Michael De | President | Sell | 7,500 | $50.85 | $381,375.00 | |
| 11/2/2016 | Tarek Sherif | CEO | Sell | 7,500 | $46.70 | $350,250.00 | |
| 10/26/2016 | Steven Isaac Hirschfeld | Vice Chairman | Sell | 10,000 | $48.50 | $485,000.00 | |
| 10/25/2016 | Michael I Otner | EVP | Sell | 7,331 | $53.87 | $394,920.97 | |
| 10/11/2016 | Vries Glen Michael De | President | Sell | 7,500 | $54.72 | $410,400.00 | |
| 10/4/2016 | Tarek Sherif | CEO | Sell | 7,500 | $54.86 | $411,450.00 | |
| 9/28/2016 | Steven Isaac Hirschfeld | Vice Chairman | Sell | 10,000 | $56.17 | $561,700.00 | |
| 9/12/2016 | Vries Glen Michael De | President | Sell | 7,500 | $53.70 | $402,750.00 | |
| 9/7/2016 | Steven Isaac Hirschfeld | Vice Chairman | Sell | 10,000 | $55.85 | $558,500.00 | |
| 9/2/2016 | Tarek Sherif | CEO | Sell | 7,500 | $54.33 | $407,475.00 | |
| 8/31/2016 | Steven Isaac Hirschfeld | Vice Chairman | Sell | 10,000 | $54.11 | $541,100.00 | |
| 8/29/2016 | Michael I Otner | EVP | Sell | 6,006 | $53.92 | $323,843.52 | |
| 8/9/2016 | Vries Glen Michael De | President | Sell | 7,500 | $54.39 | $407,925.00 | |
| 8/2/2016 | Tarek Sherif | CEO | Sell | 7,500 | $52.97 | $397,275.00 | |
| 7/29/2016 | Eileen Schloss | EVP | Sell | 2,083 | $53.04 | $110,482.32 | |
| 7/27/2016 | Steven Isaac Hirschfeld | Vice Chairman | Sell | 10,000 | $52.77 | $527,700.00 | |
| 7/26/2016 | Eileen Schloss | EVP | Sell | 10,644 | $52.82 | $562,216.08 | |
| 7/22/2016 | Michael I. Otner | EVP | Sell | 7,500 | $51.27 | $384,525.00 | |
| 7/20/2016 | Steven Isaac Hirschfeld | Vice Chairman | Sell | 20,825 | $52.89 | $1,101,434.25 | |
| 7/12/2016 | Steven Isaac Hirschfeld | Vice Chairman | Sell | 10,000 | $49.85 | $498,500.00 | |
| 7/12/2016 | Tarek Sherif | CEO | Sell | 22,036 | $49.24 | $1,085,052.64 | |
| 7/12/2016 | Vries Glen Michael De | President | Sell | 32,500 | $49.25 | $1,600,625.00 | |
| 7/5/2016 | Tarek Sherif | CEO | Sell | 7,500 | $46.35 | $347,625.00 | |
| 6/29/2016 | Steven Isaac Hirschfeld | Vice Chairman | Sell | 10,000 | $45.66 | $456,600.00 | |
| 6/9/2016 | Vries Glen Michael De | President | Sell | 7,500 | $47.66 | $357,450.00 | |
| 6/2/2016 | Tarek Sherif | CEO | Sell | 7,500 | $45.90 | $344,250.00 | |
| 5/31/2016 | Robert Taylor | Director | Sell | 3,752 | $45.03 | $168,952.56 | |
| 5/25/2016 | Neil M Kurtz | Director | Sell | 5,937 | $44.95 | $266,868.15 | |
| 5/25/2016 | Steven Isaac Hirschfeld | Vice Chairman | Sell | 10,000 | $44.94 | $449,400.00 | |
| 5/25/2016 | Tarek Sherif | CEO | Sell | 7,500 | $45.00 | $337,500.00 | |
| 4/27/2016 | Steven Isaac Hirschfeld | Vice Chairman | Sell | 10,000 | $45.09 | $450,900.00 | |
| 4/25/2016 | Eileen Schloss | EVP | Sell | 68,717 | $46.53 | $3,197,402.01 | |
| 4/25/2016 | Vries Glen Michael De | President | Sell | 7,500 | $46.36 | $347,700.00 | |
| 2/16/2016 | Lee Shapiro | Director | Buy | 1,500 | $33.45 | $50,175.00 | |
| 7/21/2015 | Steven Isaac Hirschfeld | Insider | Sell | 5,293 | $61.00 | $322,873.00 | |
| 7/20/2015 | Steven Isaac Hirschfeld | Insider | Sell | 4,908 | $59.00 | $289,572.00 | |
| 5/29/2015 | Eileen Schloss | EVP | Sell | 2,084 | $57.10 | $118,996.40 | |
| 5/29/2015 | Robert Taylor | Director | Sell | 5,048 | $56.81 | $286,776.88 | |
| 5/14/2015 | Steven Isaac Hirschfeld | Insider | Sell | 22,153 | $53.36 | $1,182,084.08 | |
| 4/29/2015 | Eileen Schloss | EVP | Sell | 4,166 | $55.20 | $229,963.20 | |
| 4/28/2015 | Cory Douglas | CFO | Sell | 12,333 | $55.29 | $681,891.57 | |
| 3/23/2015 | Vries Glen Michael De | President | Sell | 20,000 | $49.89 | $997,800.00 | |
| 2/18/2015 | Eileen Schloss | EVP | Sell | 12,065 | $46.98 | $566,813.70 | |
| 2/17/2015 | Michael I Otner | EVP | Sell | 11,010 | $46.75 | $514,717.50 | |
| 2/10/2015 | Bryan Charles Spielman | EVP | Sell | 5,851 | $45.00 | $263,295.00 | |
| 2/10/2015 | Robert Taylor | Director | Sell | 28,672 | $44.07 | $1,263,575.04 | |
| 2/9/2015 | Cory Douglas | CFO | Sell | 38,000 | $44.24 | $1,681,120.00 | |
| 2/9/2015 | Eileen Schloss | EVP | Sell | 12,499 | $44.43 | $555,330.57 | |
| 12/4/2014 | Steven Isaac Hirschfeld | Insider | Sell | 22,075 | $42.53 | $938,849.75 | |
| 11/19/2014 | Michael L Capone | COO | Buy | 2,400 | $40.01 | $96,024.00 | |
| 10/3/2014 | Tarek Sherif | CEO | Sell | 20,000 | $45.30 | $906,000.00 | |
| 9/9/2014 | Vries Glen Michael De | President | Sell | 20,000 | $48.51 | $970,200.00 | |
| 8/26/2014 | Bryan Charles Spielman | EVP | Sell | 20,000 | $47.73 | $954,600.00 | |
| 8/22/2014 | Steven Isaac Hirschfeld | EVP | Sell | 23,801 | $44.00 | $1,047,244.00 | |
| 8/7/2014 | Michael I Otner | EVP | Sell | 10,000 | $44.84 | $448,400.00 | |
| 8/5/2014 | Tarek Sherif | CEO | Sell | 20,000 | $44.81 | $896,200.00 | |
| 8/4/2014 | Bryan Charles Spielman | EVP | Sell | 2,261 | $45.00 | $101,745.00 | |
| 7/8/2014 | Vries Glen Michael De | President | Sell | 20,000 | $40.13 | $802,600.00 | |
| 7/7/2014 | Tarek Sherif | CEO | Sell | 20,000 | $43.20 | $864,000.00 | |
| 6/17/2014 | Tarek Sherif | CEO | Sell | 19,818 | $40.27 | $798,070.86 | |
| 6/17/2014 | Vries Glen Michael De | President | Sell | 20,000 | $40.26 | $805,200.00 | |
| 4/8/2014 | Vries Glen Michael De | President | Sell | 20,000 | $47.71 | $954,200.00 | |
| 4/3/2014 | Tarek Sherif | CEO | Sell | 20,000 | $55.05 | $1,101,000.00 | |
| 2/19/2014 | Eileen Schloss | EVP | Sell | 16,847 | $60.76 | $1,023,623.72 | |
| 2/18/2014 | Steven Isaac Hirschfeld | EVP | Sell | 17,000 | $60.03 | $1,020,510.00 | |
| 2/11/2014 | Vries Glen Michael De | President | Sell | 20,000 | $54.40 | $1,088,000.00 | |
| 1/14/2014 | Vries Glen Michael De | President | Sell | 20,000 | $59.35 | $1,187,000.00 | |
| 1/6/2014 | Tarek Sherif | CEO | Sell | 20,000 | $59.44 | $1,188,800.00 | |
| 12/13/2013 | Steven Isaac Hirschfeld | EVP | Sell | 10,000 | $113.01 | $1,130,100.00 | |
| 12/11/2013 | Steven Isaac Hirschfeld | EVP | Sell | 10,000 | $116.59 | $1,165,900.00 | |
| 12/10/2013 | Vries Glen Michael De | President | Sell | 10,000 | $116.39 | $1,163,900.00 | |
| 12/6/2013 | Tarek Sherif | CEO | Sell | 53,290 | $118.08 | $6,292,483.20 | |
| 12/6/2013 | Vries Glen Michael De | President | Sell | 43,289 | $118.11 | $5,112,863.79 | |
| 11/12/2013 | Cory Douglas | CFO | Sell | 10,000 | $108.08 | $1,080,800.00 | |
| 11/1/2013 | Cory Douglas | CFO | Sell | 30,000 | $109.59 | $3,287,700.00 | |
| 10/29/2013 | Eileen Schloss | EVP | Sell | 12,500 | $116.08 | $1,451,000.00 | |
| 10/28/2013 | Lee Shapiro | Director | Sell | 3,800 | $117.48 | $446,424.00 | |
| 10/28/2013 | Michael I Otner | EVP | Sell | 5,071 | $117.45 | $595,588.95 | |
| 9/16/2013 | Bryan Charles Spielman | EVP | Sell | 3,905 | $99.47 | $388,430.35 | |
| 8/1/2013 | Michael I Otner | EVP | Sell | 2,500 | $92.16 | $230,400.00 | |
| 7/26/2013 | Vries Glen Michael De | President | Sell | 56,547 | $90.08 | $5,093,753.76 | |
| 7/25/2013 | Bryan Charles Spielman | EVP | Sell | 4,145 | $86.66 | $359,205.70 | |
| 7/1/2013 | Bryan Charles Spielman | EVP | Sell | 3,950 | $78.78 | $311,181.00 | |
| 6/28/2013 | Steven Isaac Hirschfeld | EVP | Sell | 5,486 | $76.84 | $421,544.24 | |
| 6/5/2013 | Steven Isaac Hirschfeld | EVP | Sell | 5,189 | $68.84 | $357,210.76 | |
| 5/22/2013 | Steven Isaac Hirschfeld | EVP | Sell | 10,711 | $67.60 | $724,063.60 | |
| 5/10/2013 | Robert Taylor | Director | Sell | 4,533 | $70.31 | $318,715.23 | |
| 5/1/2013 | Neil M Kurtz | Director | Sell | 5,910 | $66.02 | $390,178.20 | |
| 2/25/2013 | Lineene Norris Krasnow | EVP | Sell | 18,690 | $50.39 | $941,789.10 | |
| 2/22/2013 | Vries Glen Michael De | President | Sell | 56,547 | $50.20 | $2,838,659.40 | |
| 10/4/2012 | Tarek Sherif | CEO | Sell | 40,000 | $39.47 | $1,578,800.00 | |
| 10/3/2012 | Vries Glen Michael De | President | Sell | 27,604 | $39.77 | $1,097,811.08 | |
(Data available from 1/1/2013 forward)
Headline Trends for Medidata Solutions (NASDAQ:MDSO)
Latest Headlines for Medidata Solutions (NASDAQ:MDSO)
| Source: |
|
| Date | Headline |
|---|
 | Michael L. Capone Sells 5,000 Shares of Medidata Solutions, Inc. (MDSO) Stock
www.americanbankingnews.com - August 17 at 7:58 PM |
 | Fosun Pharma Selects Medidata’s Unified Platform for Clinical Development in China
finance.yahoo.com - August 17 at 2:27 AM |
| Medidata Solutions, Inc. (MDSO) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - August 15 at 4:37 PM |
| See what the IHS Markit Score report has to say about Medidata Solutions Inc.
finance.yahoo.com - August 12 at 7:45 PM |
| Zacks: Analysts Anticipate Medidata Solutions, Inc. (NASDAQ:MDSO) Will Post Quarterly Sales of $141.03 Million
www.americanbankingnews.com - August 11 at 1:48 PM |
| IHS Markit Score downgrades Medidata Solutions Inc to 32 out of 100, ranking positively in only one out of three available IHS Markit categories.
finance.yahoo.com - August 10 at 5:01 AM |
| Brokerages Expect Medidata Solutions, Inc. (MDSO) Will Post Earnings of $0.19 Per Share
www.americanbankingnews.com - August 9 at 12:24 PM |
| Medidata Earns Recognition as Leading Innovative Company and a Great Place to Work®
finance.yahoo.com - August 7 at 7:53 PM |
| Medidata Solutions, Inc. – Value Analysis (NASDAQ:MDSO) : August 7, 2017
finance.yahoo.com - August 7 at 7:53 PM |
| Medidata Solutions, Inc. breached its 50 day moving average in a Bullish Manner : MDSO-US : August 4, 2017
finance.yahoo.com - August 5 at 2:39 AM |
| Verint Systems (VRNT) & Medidata Solutions (MDSO) Head-To-Head Survey
www.americanbankingnews.com - July 29 at 8:21 AM |
| Medidata Solutions, Inc. breached its 50 day moving average in a Bullish Manner : MDSO-US : July 25, 2017
finance.yahoo.com - July 25 at 11:50 PM |
| Medidata Expands Partnership with BeiGene to use Medidata’s Patient Cloud ePRO Solution
finance.yahoo.com - July 24 at 6:30 PM |
| Medidata Solutions, Inc. (MDSO) Stock Rating Reaffirmed by Citigroup Inc.
www.americanbankingnews.com - July 24 at 5:58 PM |
| FY2017 Earnings Estimate for Medidata Solutions, Inc. (NASDAQ:MDSO) Issued By SunTrust Banks
www.americanbankingnews.com - July 24 at 8:19 AM |
| Medidata Solutions, Inc. (MDSO) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - July 22 at 12:56 AM |
| Medidata Solutions, Inc. (MDSO) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - July 21 at 4:59 PM |
| Needham & Company LLC Reiterates "Buy" Rating for Medidata Solutions, Inc. (MDSO)
www.americanbankingnews.com - July 21 at 1:44 PM |
| Q3 2017 EPS Estimates for Medidata Solutions, Inc. Lowered by Analyst (NASDAQ:MDSO)
www.americanbankingnews.com - July 21 at 9:24 AM |
| “Nature Reviews Drug Discovery” Publishes New Findings on Trial Complexity Based Upon Benchmark Data from Medidata
finance.yahoo.com - July 21 at 2:09 AM |
| Medidata Solutions, Inc. (NASDAQ:MDSO) Given New $86.00 Price Target at Morgan Stanley
www.americanbankingnews.com - July 20 at 9:32 PM |
| Brokerages Anticipate Medidata Solutions, Inc. (NASDAQ:MDSO) Will Announce Earnings of $0.21 Per Share
www.americanbankingnews.com - July 20 at 7:56 AM |
 | Medidata Solutions' (MDSO) CEO Tarek Sherif on Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - July 19 at 4:20 AM |
| Investor Network: Medidata Solutions, Inc. to Host Earnings Call
finance.yahoo.com - July 18 at 11:17 PM |
| Medidata Reports Record Second Quarter 2017 Results
finance.yahoo.com - July 18 at 11:17 PM |
| Veeva Turns the Tables in Fight Over Tech Hiring Barriers
finance.yahoo.com - July 18 at 11:17 PM |
| Medidata beats Street 2Q forecasts
finance.yahoo.com - July 18 at 11:17 PM |
| Edited Transcript of MDSO earnings conference call or presentation 18-Jul-17 12:00pm GMT
finance.yahoo.com - July 18 at 11:17 PM |
| Medidata Solutions, Inc. (MDSO) Given New $87.00 Price Target at J P Morgan Chase & Co
www.americanbankingnews.com - July 18 at 4:17 PM |
| Medidata Solutions, Inc. (MDSO) Issues Earnings Results, Beats Estimates By $0.03 EPS
www.americanbankingnews.com - July 18 at 11:39 AM |
| Medidata Solutions beats by $0.03, beats on revenue
seekingalpha.com - July 18 at 6:48 AM |
| Medidata Solutions, Inc. (NASDAQ:MDSO) to Release Quarterly Earnings on Tuesday
www.americanbankingnews.com - July 14 at 8:02 AM |
| Worldwide Clinical Trials Selects Medidata to Streamline Clinical Site Reimbursements Across the Globe
finance.yahoo.com - July 13 at 6:39 AM |
| Medidata Successfully Hosts Annual European NEXT Conference Series
finance.yahoo.com - July 13 at 6:39 AM |
| ETFs with exposure to Medidata Solutions, Inc. : July 10, 2017
finance.yahoo.com - July 11 at 1:29 AM |
| Medidata Solutions, Inc. (MDSO) Receives "Buy" Rating from Citigroup Inc.
www.americanbankingnews.com - July 10 at 4:54 PM |
| Piper Jaffray Companies Increases Medidata Solutions, Inc. (MDSO) Price Target to $87.00
www.americanbankingnews.com - July 8 at 12:22 AM |
 | Medidata Solutions Reaches Analyst Target Price
www.nasdaq.com - July 7 at 7:18 AM |
| Medidata Schedules Second Quarter Earnings Conference Call for July 18, 2017
finance.yahoo.com - July 5 at 9:23 PM |
| Chugai Deploys RaveX to Modernize Post-Marketing Surveillance
finance.yahoo.com - June 30 at 1:25 AM |
| $134.46 Million in Sales Expected for Medidata Solutions, Inc. (MDSO) This Quarter
www.americanbankingnews.com - June 28 at 1:12 PM |
| ETFs with exposure to Medidata Solutions, Inc. : June 27, 2017
finance.yahoo.com - June 27 at 6:37 PM |
| SunTrust Banks, Inc. Increases Medidata Solutions, Inc. (MDSO) Price Target to $90.00
www.americanbankingnews.com - June 27 at 8:33 AM |
| Medidata Solutions, Inc. :MDSO-US: Earnings Analysis: Q1, 2017 By the Numbers : June 26, 2017
finance.yahoo.com - June 27 at 2:31 AM |
| Theracos More Effectively Manages Both Data and Content with Medidata’s eTMF and eTMF Archive Solutions
finance.yahoo.com - June 27 at 2:31 AM |
| Medidata Solutions, Inc. (MDSO) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - June 26 at 4:32 PM |
| inVentiv Health Selects Medidata Enroll®, Medidata’s eConsent Platform, to Accelerate Clinical Trials
finance.yahoo.com - June 26 at 9:10 AM |
| Brokerages Expect Medidata Solutions, Inc. (MDSO) to Post $0.17 Earnings Per Share
www.americanbankingnews.com - June 26 at 8:24 AM |
| Median Technologies and Medidata Partner to Deliver Differentiated Image Management Services in Clinical Trials
finance.yahoo.com - June 22 at 8:45 AM |
| Sponsors and CROs Rely on Analytics in Clinical Research but Are Limited to Traditional and In-House Data, Medidata Finds
finance.yahoo.com - June 21 at 7:36 PM |
Medidata Solutions (MDSO) Chart for Monday, August, 21, 2017
